疾病中的血小板异质性:众多且多样?
本综述阐述循环血小板在起源(巨核细胞多样性)、循环年龄(年轻与衰老血小板)以及心血管和炎症疾病中表现出显著异质性,不同亚群对止血、血栓形成和炎症贡献不同;识别疾病中的血小板异质性可能为精准医学提供机会,有望实现血栓风险分层及抗血小板和抗炎治疗的差异化定制。
要点
- 网状血小板(RPs)新释放自骨髓、富含RNA且高度促血栓,衰老血小板受体表达改变并呈促炎而非止血特征。
- 高反应性RPs驱动动脉血栓形成,促凝血血小板在静脉血栓栓塞中放大纤维蛋白形成。
- 慢性炎症中免疫反应性血小板与白细胞亚群相互作用促进其招募并影响极化,也可促进内皮功能障碍和免疫过度激活。
核心结论
- 识别疾病发病机制中的血小板异质性可能为精准医学提供新机会,有望实现血栓风险分层及抗血小板和抗炎治疗的差异化定制。
研究设计与样本
- 综述,检索范围原文未报告。
主要发现
- 循环血小板表现出显著异质性,不同群体对止血、血栓形成和炎症的贡献不同。
- 血小板多样性源于起源(即巨核细胞多样性)和循环年龄(即年轻与衰老血小板),并作为心血管和炎症疾病的后遗症及促进因素。
- 网状血小板(RPs)新释放自骨髓、富含RNA且高度促血栓,而衰老血小板受体表达改变并呈促炎而非止血特征。
- 高反应性RPs驱动动脉血栓形成,促凝血血小板在静脉血栓栓塞中放大纤维蛋白形成。
- 慢性炎症中免疫反应性血小板与白细胞亚群相互作用促进其招募并影响极化,也可促进内皮功能障碍和免疫过度激活,延续血栓炎症失调。
关键数值与推荐
- 原文未报告具体标准或数值。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Platelets in peripheral blood critically drive clot formation in health and disease. Previously considered to uniformly respond to vascular injury and inflammatory cues, recent studies have highlighted that circulating platelets exhibit marked heterogeneity, with distinct populations contributing differentially to hemostasis, thrombosis, and inflammation. In this review, we highlight platelet diversity as a consequence of origin (ie, megakaryocyte diversity), circulatory age (ie, young vs aged platelets), and, specifically, as both a sequela of and a contributing factor to cardiovascular and inflammatory diseases. This diversity includes reticulated platelets (RPs), newly released from the bone marrow, RNA-rich, and highly prothrombotic, vs aged platelets, which exhibit altered receptor expression and proinflammatory rather than hemostatic features. We further describe how platelet subsets actively shape disease progression. Hyperreactive RPs drive arterial thrombosis, whereas procoagulant platelets amplify fibrin formation in venous thromboembolism. In chronic inflammation, interactions of immune-responsive platelets with leukocyte subsets facilitate their recruitment and impact on polarization, but can also promote endothelial dysfunction and immune hyperactivation, perpetuating thromboinflammatory dysregulation. Moreover, platelet phenotypes are dynamically regulated by disease states, with systemic inflammation, altered shear forces, and metabolic stress influencing platelet turnover, activation thresholds, and functional specialization. Recognizing platelet heterogeneity in disease pathogenesis could provide new opportunities for precision medicine, potentially allowing stratification of thrombotic risk and differential tailoring of antiplatelet and anti-inflammatory therapies.
引用
- Kaiser R, Anjum A, Nicolai L, et al. Platelet heterogeneity in disease: the many and the diverse? Blood. 2025. PMID: 40906924. doi:10.1182/blood.2025028957
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。